Design Therapeutics Inc Cash Flow-to-Debt Ratio
Design Therapeutics Inc cash flow-to-debt ratio. Design Therapeutics Inc (DSGN) has a Cash Flow-to-Debt Ratio of -0.93x as of September 2025, meaning its operating cash flow of $-11.16 Million could theoretically repay -1% of its total liabilities ($12.05 Million) in one year. See Design Therapeutics Inc (DSGN) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Design Therapeutics Inc (2019–2024)
Cash flow-to-debt ratio of Design Therapeutics Inc from 2019 to 2024. Historical debt coverage capacity for Design Therapeutics Inc across 6 annual periods. See DSGN equity financing ratio to measure how much of total assets are equity-financed.
Design Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2019–2024)
Design Therapeutics Inc cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Design Therapeutics Inc. For the full cash flow conversion analysis, see DSGN operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.31x | $-43.10 Million | $10.00 Million | ▲ +12.0% |
| 2023 | -4.90x | $-58.56 Million | $11.96 Million | ▼ -32.0% |
| 2022 | -3.71x | $-51.32 Million | $13.83 Million | ▼ -6.5% |
| 2021 | -3.49x | $-29.38 Million | $8.43 Million | ▼ -1823.4% |
| 2020 | -0.18x | $-8.67 Million | $47.83 Million | ▼ -386.6% |
| 2019 | -0.04x | $-139.00K | $3.73 Million | — |